Combination Adjuvant Chemotherapy + Radiation Therapy vs Radiation Alone for High Risk Endometrial Carcinoma: Final Report From PORTEC-3

June 2-6, 2017; Chicago, Illinois
Combination RT + CT improved 5-year failure-free survival by 11% in patients with stage III disease.
Format: Microsoft PowerPoint (.ppt)
File Size: 665 KB
Released: June 4, 2017

Acknowledgements

Supported by educational grants by
AbbVie
Amgen
AstraZeneca
Celgene Corporation
Genentech
Halozyme Therapeutics
Incyte
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings